Millendo Therapeutics Inc
NASDAQ:MLND (6/25/2021, 7:00:01 PM)
After market: 1.06 0 (0%)1.06
-0.06 (-5.36%)
Millendo Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Ann Arbor, Michigan. The company went IPO on 2012-10-04. Tempest Therapeutics, Inc.(Tempest), formerly Millendo Therapeutics, Inc., is a clinical-stage oncology company. The firm is focused on developing therapeutics that combine both targeted and immune-mediated mechanisms to treat a wide range of tumors. The Company’s two clinical programs are TPST-1495 and TPST-1120. The firm's both TPST-1495 and TPST-1120 are advancing through Phase 1 studies designed to study both agents as monotherapies and in combination with other approved agents. Tempest is also developing an orally-available inhibitor of TREX-1 designed to activate cGAS/STING pathway, an innate immune response pathway important for the development of anti-tumor immunity.
Millendo Therapeutics Inc
Ann Arbor MICHIGAN 48104
P: 17348459000.0
CEO: Louis Arcudi
Tempest to Trade on Nasdaq Public Markets Under Ticker “TPST”
NEW YORK, NY / ACCESSWIRE / May 25, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Ferro Corporation (NYSE:FOE) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Prince International Corporation for $22.00 per share in cash. If you are a Ferro shareholder, click here to learn more about your rights and
Here you can normally see the latest stock twits on MLND, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: